以细菌幽灵为载体和佐剂的新型淋病奈瑟菌DNA疫苗的设计与免疫特性表征
本研究设计了一种由细菌幽灵递送的新型淋病奈瑟菌DNA疫苗,并在体外和体内表征其免疫应答。结果显示细菌幽灵促进BMDCs成熟与活化,负载疫苗的细菌幽灵可被小鼠巨噬细胞RAW264.7高效摄取;口服免疫该候选疫苗较单独淋病奈瑟菌DNA疫苗诱导更强的CD4+和CD8+ T细胞应答及更高IgG应答,并显著提升杀菌抗体滴度。结果提示细菌幽灵可能通过促进BMDCs成熟发挥疫苗佐剂作用。
要点
- 细菌幽灵促进BMDCs成熟与活化。
- 负载淋病奈瑟菌DNA疫苗的细菌幽灵可被小鼠巨噬细胞RAW264.7高效摄取。
- 口服候选疫苗较单独DNA疫苗诱导更强CD4+、CD8+ T细胞和更高IgG应答,杀菌抗体滴度显著升高。
核心结论
- 细菌幽灵可能通过促进BMDCs成熟发挥疫苗佐剂作用,进而增强对疫苗抗原的免疫应答。
- 本研究凸显细菌幽灵作为抗原递送系统用于开发有效淋病疫苗的潜力。
研究设计与样本
- 设计新型淋病奈瑟菌DNA疫苗并由细菌幽灵递送,在体外和体内表征免疫应答。
- 体外采用小鼠骨髓来源树突状细胞(BMDCs)和小鼠巨噬细胞RAW264.7。
- 体内采用小鼠口服免疫,比较候选疫苗与单独淋病奈瑟菌DNA疫苗的免疫应答。
主要发现
- 细菌幽灵大幅促进BMDCs成熟与活化。
- 负载淋病奈瑟菌DNA疫苗的细菌幽灵被小鼠巨噬细胞RAW264.7高效摄取。
- 口服候选疫苗较单独淋病奈瑟菌DNA疫苗诱导更强的CD4+和CD8+ T细胞应答及更高IgG应答。
- 候选疫苗免疫小鼠的杀菌抗体滴度显著升高。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Gonorrhea, an important sexually transmitted disease, is becoming a growing public health problem around the globe. Vaccination is considered the best long-term approach for control of infection. In this study, we designed a novel Neisseria gonorrhoeae (N. gonorrhoeae) DNA vaccine delivered by bacterial ghosts and characterized its immune responses in vitro and in vivo. Our results demonstrate that bacterial ghosts greatly promoted BMDCs maturation and activation. Bacterial ghosts loaded with N. gonorrhoeae DNA vaccine were efficiently taken up by mouse macrophage RAW264.7 cells. Furthermore, oral immunization with the ghost vaccine candidate elicited greater CD4+ and CD8+ T cell responses and induced higher IgG responses than N. gonorrhoeae DNA vaccine alone. In addition, mice immunized with the vaccine candidate responded with a significant rise in bactericidal antibody titer. These results suggest that bacterial ghosts may function as a vaccine adjuvant by promoting BMDCs maturation, which in turn enhances the immune responses to the vaccine antigens. This study also highlights the potential of using bacterial ghosts as antigen delivery system in the development of an efficacious gonorrhea vaccine.
引用
- Jiao H, Yang H, Zhao D, et al. Design and immune characterization of a novel Neisseria gonorrhoeae DNA vaccine using bacterial ghosts as vector and adjuvant. Vaccine. 2018. PMID: 29914847. doi:10.1016/j.vaccine.2018.06.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。